Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Pathology

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.humpath.2012.01.018PMID 22569213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Iconografías adicionales del artículo : TMPRSS2-ERG Fusion Heterogeneity in Multifocal Prostate Cancer: Clinical and Biologic Implications

  2011cited by this paper
• TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate.

  2011cited by this paper
• Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.

  2011cited by this paper
• Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer

  2011cited by this paper
• Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation

  2011cited by this paper
• Common gene rearrangements in prostate cancer.

  2011influential reference
• ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression

  2010cited by this paper
• ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples

  2010cited by this paper
• ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

  2010cited by this paper
• ERG rearrangement metastasis patterns in locally advanced prostate cancer.

  2010cited by this paper
• Testing mutual exclusivity of ETS rearranged prostate cancer

  2010cited by this paper
• The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells.

  2010cited by this paper
• ERG rearrangement in small cell prostatic and lung cancer

  2010cited by this paper
• Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

  2009cited by this paper
• Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma

  2009cited by this paper
• ETS gene fusions in prostate cancer: from discovery to daily clinical practice.

  2009cited by this paper
• N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.

  2009cited by this paper
• SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.

  2009cited by this paper
• A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.

  2008cited by this paper
• Recurrent gene fusions in prostate cancer

  2008cited by this paper
• Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

  2008cited by this paper
• TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation

  2008cited by this paper
• Prostatic preneoplasia and beyond.

  2008cited by this paper
• CHARACTERIZATION OF TMPRSS2-ETS GENE ABERRATIONS IN ANDROGEN INDEPENDENT METASTATIC PROSTATE CANCER

  2008influential reference
• Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.

  2008cited by this paper
• Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.

  2008cited by this paper
• Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.

  2008cited by this paper
• Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007.

  2007cited by this paper
• Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

  2007cited by this paper
• Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

  2007cited by this paper
• TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.

  2006cited by this paper
• TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

  2006influential reference
• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006influential reference
• TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.

  2006cited by this paper
• ETS transcription factors: Possible targets for cancer therapy

  2004cited by this paper
• Effect of Bone Decalcification Procedures on DNA In Situ Hybridization and Comparative Genomic Hybridization: EDTA Is Highly Preferable to a Routinely Used Acid Decalcifier

  1999cited by this paper

• Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression

  2024cites this paper
• Unveiling Prostate Cancer's Molecular Tapestry: Ethnic Disparities and Prognostic Insights from Whole-Mount Prostatectomy Tissue Analysis

  2024cites this paper
• Experimental challenges to modeling prostate cancer heterogeneity.

  2021cites this paper
• E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms

  2021cites this paper
• Role of the COP1 protein in cancer development and therapy.

  2020cites this paper
• ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BB

  2019cites this paper
• ceRNA network analysis reveals prognostic markers for glioblastoma

  2019cites this paper
• Five ETS family members, ELF-1, ETV-4, ETV-3L, ETS-1, and ETS-2 upregulate human leukocyte-associated immunoglobulin-like receptor-1 gene basic promoter activity

  2018cites this paper
• Genetic profile of ductal adenocarcinoma of the prostate.

  2017cites this paper
• Identification and characterisation of novel cancer testis antigens in human cancer cells

  2017cites this paper
• Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts

  2015cites this paper
• Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1–FEV translocation

  2014cites this paper
• Significantly higher expression levels of androgen receptor are associated with erythroblastosis virus E26 oncogene related gene positive prostate cancer.

  2014cites this paper
• ETS fusion genes in prostate cancer.

  2014cites this paper
• Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era

  2013cites this paper
• Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer

  2013cites this paper
• Significance of the TMPRSS2:ERG gene fusion in prostate cancer

  2013cites this paper
• ETV1 positively regulates transcription of tumor suppressor ARF

  2013cites this paper
• Androgeenireseptorin tumatranslokaatio, FOXA1-vuorovaikutus ja liikkuvuus ihmisen soluissa

  2012cites this paper
• ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer

  2012cites this paper